Ultragenyx Pharmaceutical Inc. buy Stifel Nicolaus
Start price
31.05.24
/
50%
€37.00
Target price
31.05.25
€116.79
Performance (%)
-20.00%
End price
01.06.25
€29.60
Summary
This prediction ended on 01.06.25 with a price of €29.60. The prediction for Ultragenyx Pharmaceutical Inc. disappointed with a performance of -20.00%. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.966% | -7.966% | 1.595% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% |
Comments by Stifel_Nicolaus for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Stifel Nicolaus from $124.00 to $127.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten